|Videos|January 24, 2015
Regulatory, Accreditation Standards to Consider Regarding Radiopharmaceuticals
Patricia Kienle, MPA, FASHP, director of accreditation and medical safety at Cardinal Health, talks about which regulatory and accreditation standards pharmacy directors should pay attention to with regard to radiopharmaceuticals.
Advertisement
Patricia Kienle, MPA, FASHP, director of accreditation and medical safety at Cardinal Health, talks about which regulatory and accreditation standards pharmacy directors should pay attention to with regard to radiopharmaceuticals.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expanded Approval of Imiglucerase Expands Treatment Options for Type 3 Gaucher Disease
2
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
3
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
4
FDA Draft Guidance Signals Shift Toward MRD, Complete Response as Accelerated Approval End Points in Multiple Myeloma
5